| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 0.00 | 0.00 | 1.25K | 0.00 | 0.00 |
| Gross Profit | 26.57K | -65.28K | -633.04K | -1.30K | -330.75K |
| EBITDA | -1.56M | 0.00 | 643.12K | -2.64M | -797.65K |
| Net Income | -2.26M | -1.43M | -1.77M | -2.64M | -797.65K |
Balance Sheet | |||||
| Total Assets | 1.63M | 570.66K | 488.85K | 523.29K | 523.29K |
| Cash, Cash Equivalents and Short-Term Investments | 723.12K | 16.67K | 45.46K | 12.36K | 1.11M |
| Total Debt | 1.21M | 599.39K | 102.29K | 326.29K | 326.29K |
| Total Liabilities | 2.81M | 2.10M | 1.01M | 1.35M | 1.35M |
| Stockholders Equity | -1.18M | -1.53M | -520.65K | -824.59K | 601.44K |
Cash Flow | |||||
| Free Cash Flow | -445.46K | -397.24K | -1.62M | -2.37M | -285.17K |
| Operating Cash Flow | -445.46K | -369.12K | -1.62M | -2.32M | -285.17K |
| Investing Cash Flow | -366.12K | -28.12K | 0.00 | -51.48K | 0.00 |
| Financing Cash Flow | 1.47M | 370.85K | 1.66M | 1.27M | 1.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
52 Neutral | £43.72M | -20.06 | ― | ― | ― | -36.54% | |
50 Neutral | £4.20M | ― | ― | ― | ― | ― | |
50 Neutral | £2.08M | ― | ― | ― | ― | ― | |
49 Neutral | £362.66K | ― | ― | ― | ― | ― | |
42 Neutral | £600.00K | -4.04 | ― | ― | ― | ― | |
41 Neutral | £298.77K | ― | ― | ― | ― | ― |
Alkemy Capital Investments Plc has received a loan conversion notice from its debt facility provider, converting £236,363.64 of principal and £8,943.96 of interest into equity at £3.48 per share, resulting in the issuance of 70,446 new ordinary shares and 46,749 warrants exercisable at £4.01 over 48 months. Application will be made for the new shares to be admitted to trading on the London Stock Exchange’s Main Market on 4 February 2026, after which the company’s enlarged share capital will comprise 10,733,038 ordinary shares, a change that modestly alters its capital structure and voting rights denominator for shareholders under FCA disclosure rules.
The most recent analyst rating on (GB:ALK) stock is a Sell with a £372.00 price target. To see the full list of analyst forecasts on Alkemy Capital Investments Plc stock, see the GB:ALK Stock Forecast page.
Alkemy Capital Investments’ subsidiary Tees Valley Lithium has signed a five-year binding offtake agreement with a wholly owned Glencore unit for the supply of between 25,000 and 50,000 tonnes of battery-grade lithium hydroxide from its planned Teesside refinery, with deliveries to start in line with targeted production in early 2028. The deal, covering up to 10,000 tonnes a year and including standard commercial terms, secures a substantial portion of capacity from TVL’s initial 25,000-tonne-per-year production train, marking a key milestone ahead of final investment decision on what is set to be the UK’s first large-scale lithium hydroxide refinery and reinforcing both Alkemy’s strategic role in the European EV battery supply chain and Glencore’s position as a leading supplier of battery raw materials in the region.
The most recent analyst rating on (GB:ALK) stock is a Hold with a £383.00 price target. To see the full list of analyst forecasts on Alkemy Capital Investments Plc stock, see the GB:ALK Stock Forecast page.
Alkemy Capital Investments said the Front-End Engineering Design (FEED) study for its Tees Valley Lithium refinery in Teesside is over 90% complete and on track to confirm the plant as one of Europe’s lowest capital and operating cost lithium refining facilities. The project has finalized process design with Veolia, targeting lithium recovery above 94%, a fully electrified configuration that removes natural gas use in favour of renewable power, and major gains in water recirculation and layout efficiency, while independent validation and strong engagement from more than 340 local and national suppliers bolster execution readiness and position the refinery as a key low-cost, low-carbon node in the UK and European battery materials supply chain amid a strengthening lithium market.
The most recent analyst rating on (GB:ALK) stock is a Hold with a £241.00 price target. To see the full list of analyst forecasts on Alkemy Capital Investments Plc stock, see the GB:ALK Stock Forecast page.
Alkemy Capital Investments Plc has announced a loan conversion resulting in the issuance of 90,572 new ordinary shares. This move will increase the company’s share capital to 10,662,592 ordinary shares, with the new shares set to be admitted to trading on the London Stock Exchange. This development is part of Alkemy’s strategic efforts to bolster its financial position and support its ongoing projects in the critical minerals sector, which are crucial for the global energy transition and the European electric vehicle market.
Alkemy Capital Investments Plc announced the exercise of warrants and a loan conversion, resulting in over £1 million in working capital to advance its Front-End Engineering Design (FEED) study for the Tees Valley Lithium project. This financial boost supports Alkemy’s strategic goal to make the Tees Valley Lithium project highly competitive internationally by reducing capital and operating costs. The company plans to secure asset-level finance and commence construction in early 2026, with strong market interest anticipated due to the project’s attractive financial metrics. The expansion of Alkemy’s share capital to 10,572,020 Ordinary Shares reflects the company’s growth and investor confidence.
Alkemy Capital Investments Plc has announced significant progress in the development of its Tees Valley Lithium project, with the Front-End Engineering Design (FEED) study advancing and project-level financing underway. The appointment of ABG Sundal Collier ASA as financial advisor marks a crucial step towards securing $245 million in bond and equity financing, aiming for a Final Investment Decision in Q1 2026. The project is set to enhance the UK’s battery materials supply chain, with operational cost improvements expected due to increased government discounts. The upcoming supply chain event will further integrate UK suppliers into the project’s construction and operation.
Alkemy Capital Investments Plc has appointed ABG Sundal Collier ASA to lead a US$245 million bond and equity financing for Tees Valley Lithium’s lithium hydroxide refinery project in Teesside. This financing will fund the construction of the first train of the refinery, expected to produce 25,000 tonnes of lithium hydroxide annually, positioning TVL as a key player in Europe’s green energy transition. The funding is anticipated to be secured through a mix of bonds, government grants, and institutional equity, with a final investment decision expected in early 2026.
Alkemy Capital Investments Plc has announced the exercise of 20,000 warrants at £2.00 each, resulting in a capital influx of £40,000 and the issuance of 20,000 new ordinary shares. These shares will be admitted to trading on the London Stock Exchange on 7 November 2025, increasing the company’s total share capital to 9,966,865 ordinary shares. This move is part of Alkemy’s broader strategy to enhance its financial position and support its ongoing projects in the critical mineral and lithium supply chain sectors, potentially impacting shareholder interests and market positioning.